CBD: Novel Foods Application
Be at the fore-front of CBD novel foods – with our in-depth scientific expertise we can help you apply to the Food Standards Agency (FSA) with our full end-to-end service
Novel foods are foods that have not been widely consumed by people in the UK or EU before May 1997. This means that the foods don’t have a ‘history of consumption’. Before a novel food can be legally marketed in the UK, it is required to have a pre-market safety assessment and authorisation.
Hemp and related products, such as cold-pressed oils, are not novel because there is evidence to show a history of consumption before May 1997. This is not the case for CBD extracts.
With our own ISO 17025 accredited laboratory, ADACT is a leader in the testing of CBD products. We have designed a process to conduct testing on CBD as a novel food.
We will conduct the analytical work and stability studies needed to support your application through every step of the process and support your application with a full exposure related safety and toxicology assessment, ADME, genotoxicology assessment and allergen assessments.
The first component of the application is a feasibility assessment. This is a low cost process required to assess your readiness for a novel food application. A Good Agricultural Practice (GAP) is used to reveal everything that has happened to a crop from before it was planted, throughout the growth and harvest, and ultimately through to the final processing and delivery.
From this, we then go on to audit your own manufacturing processes and finished products. This helps us to ensure you have all the elements needed for a novel food application and to find any weaknesses early on before embarking on a formal application. This step alone instantly gives the pending application the kudos of a full bank of data.
Next, is the compilation of your actual novel food application. We are working with a number of companies who are compiling the data needed for novel food applications and because the data is very similar from one application to the next (apart from some product specific components) there is a huge opportunity to share the costs of putting together the background data.
This along with the fact all our testing is done in our own ISO 17025 accredited laboratory results in considerable cost savings for a typical customer’s complete novel food application.
There are two classes of novel food application service, CBD isolate and CBD broad spectrum. The process for CBD isolate products is clear and ADACT have been actively doing these for some time now. The process for CBD broad spectrum products is much less clear at this time.
We are developing and implementing a herbal monograph approach to CBD broad spectrum and encourage you to get in touch early on if you have products in this segment.
Fully validated, novel food authorisations need to be made by 31 March. After this date, only products for which the FSA has a valid application will be allowed to remain on the market.
Since 2019 ADACT has been a registered member of The Medical Cannabis Clinicians Society (MCCS). Through this leading network of UK clinicians, MCCS is dedicated to changing lives with medical cannabis treatments. Their mission is to bring safe, legal and effective cannabis treatments to end users by providing evidence, education, training, guidance and support.
If you aren’t sure, this download will help. Provide your details below to download our CBD Novel Food Application decision tree…
We care about our customers and ensuring they have access to affordable compliance services to enable their businesses to grow.
Compliance strengthens brands – consumers naturally have a higher level of confidence in tested, approved products. Compliant products have a leading edge in the market place, when compared to non-tested brands and products.